arrow
F

Felipe Ades

chariteuniversitatsmedizin berlin
H指数:14
被引数:1,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarker Results in High-risk Estrogen Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Primary Breast Cancer Following Neoadjuvant Chemotherapy ± Nivolumab: an Exploratory Analysis of CheckMate 7FL
2024-05-029
PRE
Repotrectinib in patients with ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC): Update from the pivotal phase 1/2 TRIDENT-1 trial
2023-12-011
PRE
A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts) with high-risk, ER+HER2L primary breast cancer (BC)
2023-10-0144
OA
OncoAlert Round Table Discussions: The Global COVID-19 Experience

OncoAlert圆桌讨论: 全球新型冠状病毒肺炎经验

2021-12-015
OAAI
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
2020-08-0420
OAAI